Schering-Plough

Last updated
Schering-Plough Corporation
Type Subsidiary
Industry Pharmaceuticals
Founded1971 (by merger with Plough, Inc.)
DefunctNovember 2009;13 years ago (2009-11)
FateMerged with Merck & Co.
Headquarters Kenilworth, New Jersey
Key people
 Fred Hassan
Final CEO & Chairman
Revenue US$18.502 billion (2008)
US$1.903 billion (2008)
Parent Merck & Co.

Schering-Plough Corporation was an American pharmaceutical company. It was originally the U.S. subsidiary of the German company Schering AG, which was founded in 1851 by Ernst Christian Friedrich Schering. As a result of nationalization, it became an independent company. In 1971, the Schering Corporation merged with Plough, Inc. (founded by Memphis-based entrepreneur Abe Plough in 1908 [1] ) to form Schering-Plough. On November 4, 2009 Merck & Co. merged with Schering-Plough with the new company taking the name of Merck & Co.

Contents

Schering-Plough manufactured several pharmaceutical drugs, the most well-known of which were the allergy drugs Claritin and Clarinex, an anti-cholesterol drug Vytorin, and a brain tumor drug Temodar. These are now available from Merck & Co. [2]

Schering-Plough also owned and operated the major foot care brand name Dr. Scholl's and the skin care line Coppertone. These also became a part of the new company. [3]

As of June 2005, Schering-Plough had 1.4% market share in the U.S., placing it seventeenth in the top twenty pharmaceutical corporations by sales compiled by IMS Health.[ citation needed ]

Schering-Plough was a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), [4] a membership which is also maintained by the new Merck & Co. [5]

History

Pharmaceuticals and consumer products

Schering was founded in 1851 by Ernst Christian Friedrich Schering as Schering AG in Germany.[ citation needed ]

Plough, Incorporated was founded by the Memphis, Tennessee area entrepreneur Abe Plough (1892–1984) in 1908. He borrowed $125 from his father to start the business at age sixteen. As a one-man business, he mixed "Plough's Antiseptic Healing Oil," a "sure cure for any ill of man or beast," and sold it off a horse-drawn buggy. [1]

Plough's acquisitions included St Joseph's Aspirin for children, [1] Maybelline cosmetics, and Coppertone skin care products. Plough also had a broadcasting division, operating radio stations in Atlanta, Georgia (WPLO-AM & FM); Baltimore, Maryland (WCAO-AM & FM); Boston, Massachusetts (WCOP-AM & FM); Chicago, Illinois (WJJD-AM & FM); and Memphis, Tennessee (WMPS-AM & FM). [6]

Following the entry of the United States into World War II in 1941, U.S. President Franklin Delano Roosevelt ordered Schering AG's U.S. assets be seized. These became the Schering Corporation. The company was placed under a government administratorship until 1952, when it was released, and its assets sold to the private sector.[ citation needed ]

In 1957, Schering acquired White Laboratories. [7]

In 1971, the Schering Corporation merged with Plough, Inc. At the time of the merger, Abe Plough became Chairman of the combined company. [8] In 2000, Schering-Plough bought a new campus in Summit, New Jersey from Novartis.[ citation needed ]

On March 12, 2007, Schering-Plough Corp. purchased Organon BioSciences, the drug unit of Netherlands-based Akzo Nobel, for $14.4 billion, giving the US pharmaceutical company an array of women's health products and numerous late-stage pipelines of experimental medicines. [9] Organon itself was founded in 1923 by Dr. Saal van Zwanenberg, the president of Zwanenberg's Slachterijen en Fabrieken.

On November 4, 2009 Schering-Plough merged with Merck & Co. and through a reverse merger, Merck became a subsidiary of Schering-Plough, which renamed itself Merck. [10] [11] [12] [13]

Animal health

Coopers Animal Health

One of Schering-Plough's plants, in Upper Hutt, New Zealand was the largest single site for the production of veterinary vaccines in the world.[ citation needed ] This was primarily because New Zealand's isolation has formed a natural quarantine, leaving the country free of rabies, foot and mouth, scrapie, bovine spongiform encephalopathy, and many other livestock diseases. It formerly had echinococcosis, but this has been eradicated. The site was known locally as Coopers Animal Health, a trademark which originated in the 1850s with a British company, Cooper & Nephews; the Coopers brand name was still in use by Schering-Plough in Australia, but not elsewhere. [14]

Intervet

As a result of the acquisition of Organon BioSciences, Schering-Plough bolstered its animal health business with the Akzo Nobel subsidiary Intervet, obtained control of the active pharmaceutical ingredient manufacturer, Diosynth and gained access to human vaccine production through the subsidiary Nobilon. The three companies comprising Organon BioSciences were Organon, Diosynth, and Intervet. [9] HomeAgain continues to use the Intervet name owned by Merck.

Merck Animal Health, MSD Animal Health

After the merger of Schering-Plough with Merck the animal health division was still known as Intervet/Schering-Plough Animal Health. [15] A merger of Merial and Intervet/Schering-Plough was planned in 2010 but was abandoned in March 2011. [16] On June 29, 2011, the company announced that the animal health division would now be known as Merck Animal Health in the United States and Canada; it is now called MSD Animal Health elsewhere in the world. [17]

Chief executives

NameTenure
Willibald H. Conzen1971 – 1979
Richard J. Bennett1979 – January 31, 1982
Robert P. LucianoFebruary 1, 1982 – December 31, 1995
Richard J. KoganJanuary 1, 1996 – April 2003
Fred Hassan April 2003 – November 3, 2009

Medical products

Prescription products

Over-the-counter products (Most products sold to Bayer, except Coppertone)

Veterinary products

Exercise drug

Schering-Plough also received much publicity for a drug AICAR which mimics the effects of exercise, having especially potent effects when used alongside another drug GW1516 developed by GlaxoSmithKline. [ citation needed ]

Collaborative research

In addition to internal research and development activities Schering-Plough was also involved in publicly funded collaborative research projects, with other industrial and academic partners. One example in non-clinical safety assessment was the InnoMed PredTox. [29] [30]

Controversy

In 2004, Schering-Plough was accused of marketing gimmicks and payoffs to doctors for prescribing the company's pharmaceutical products. [31]

Schering-Plough entered a consent decree with the FDA on March 6, 2002 due to manufacturing issues with its albuterol inhaler. It was ordered to pay $500 million US dollars to the US Treasury. [32]

Related Research Articles

<span class="mw-page-title-main">Merck Group</span> German multinational science and technology company

The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and present in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.

FUJIFILM Diosynth Biotechnologies, abbreviated FDB and also referred to simply as Diosynth, is a biopharmaceutical contract manufacturing organization that develops manufacturing processes and manufactures active ingredients and provides fill and finish services for pharmaceutical companies. FUJIFILM Diosynth Biotechnologies is the world's second largest contract manufacturer of biopharmaceuticals, with manufacturing facilities in Morrisville, North Carolina and College Station, Texas in the United States, Teesside, United Kingdom and Hillerød, Denmark in Europe, and recently added sites in Thousand Oaks, California and Watertown, Massachusetts. FUJIFILM Diosynth Biotechnologies operates a highly automated multipurpose manufacturing facility in College Station, Texas under the federal government's Center for Innovation in Advanced Development and Manufacturing (CIADM) program, which is the largest scale-out cell culture manufacturing facility in the United States.

<span class="mw-page-title-main">Pharmaceutical industry</span> Industry involved with discovery, development, production and marketing of drugs

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceuticals for use as medications to be administered to patients, with the aim to mitigate symptoms or disease conditions, vaccinate them, or alleviate symptoms of disease or surgical or disease condition. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy using drug testing and marketing of drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020 and showed a compound annual growth rate (CAGR) of 1.8%.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.

<span class="mw-page-title-main">Schering AG</span>

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006, it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

<span class="mw-page-title-main">Canine influenza</span>

Canine influenza is influenza occurring in canine animals. Canine influenza is caused by varieties of influenzavirus A, such as equine influenza virus H3N8, which was discovered to cause disease in canines in 2004. Because of the lack of previous exposure to this virus, dogs have no natural immunity to it. Therefore, the disease is rapidly transmitted between individual dogs. Canine influenza may be endemic in some regional dog populations of the United States. It is a disease with a high morbidity but a low incidence of death.

<span class="mw-page-title-main">ViroPharma</span>

ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. It was purchased by Shire in 2013, with Shire paying around $4.2 billion for the company in a deal that was finalized in January 2014. ViroPharma was a member of the NASDAQ Biotechnology Index and the S&P 600.

<span class="mw-page-title-main">Boehringer Ingelheim Animal Health</span>

Boehringer Ingelheim Animal Health is a multinational animal health company, formed in January 2017 when Merial was acquired by Boehringer Ingelheim and merged with Boehringer Ingelheim's existing animal health assets.

<span class="mw-page-title-main">Sugammadex</span> Selective relaxant binding agent

Sugammadex, sold under the brand name Bridion, is a medication for the reversal of neuromuscular blockade induced by rocuronium and vecuronium in general anaesthesia. It is the first selective relaxant binding agent (SRBA). It is marketed by Merck.

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon sells to international markets.

Fred Hassan, is a Pakistan-born American business executive who works for Warburg Pincus and was CEO of three global pharmaceutical companies.

Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ).

<span class="mw-page-title-main">Coppertone sign</span>

The original plastic, metal and neon Coppertone girl sign was designed and made in 1958 by Tropicalites, a sign company owned by Morris "Moe" Bengis. Before producing the original Coppertone Girl sign, Bengis met with Benjamin Green, who invented the Coppertone product in his kitchen in 1944 and Abe Plough, the founder of Schering-Plough; which bought Coppertone in 1957.

<span class="mw-page-title-main">Coppertone (sunscreen)</span> Brand name for an American sunscreen

Coppertone is the brand name for an American sunscreen. Coppertone is headquartered in Whippany, New Jersey. Coppertone uses a variety of branding, including the Coppertone girl logo and a distinctive fragrance.

<span class="mw-page-title-main">Newhouse Research Site</span>

The Newhouse Research Site is a drug research facility situated 15 miles (24 km) east of Glasgow in central Scotland. It is located beside the M8 motorway in Newhouse, North Lanarkshire. The site is an early drug discovery research centre with a track record of generating a succession of products in the areas of anaesthesia and psychiatry. In 2007, the Royal Society of Chemistry Malcolm Campbell Memorial Prize was awarded to researchers for its work on a new anaesthesia drug, sugammadex. It currently employs 250 scientists across a range of disciplines including medicinal chemistry, molecular biology and drug metabolism. The site is currently the largest private drug discovery centre in Scotland, and one of the biggest in the UK.

<span class="mw-page-title-main">Merck & Co.</span> American multinational pharmaceutical company

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue.

Tildrakizumab, sold under the brand names Ilumya and Ilumetri, is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adult patients with moderate-to-severe plaque psoriasis in the United States and the European Union.

<span class="mw-page-title-main">Fluralaner</span> Chemical compound

Fluralaner (INN) is a systemic insecticide and acaricide that is administered orally or topically. The U.S. Food and Drug Administration (FDA) approved it under the trade name Bravecto for flea treatment in dogs in May 2014 and Bravecto Plus as a topical treatment for cats in November 2019, with warnings about possible side effects in both species. The EU approved the drug in February 2014. Australia approved it for the treatment and prevention of ticks and fleas on dogs in January 2015.

Brent Saunders is an American biopharma executive and entrepreneur. He is known for his merger and acquisition activity, having helped oversee the merger between pharmaceutical companies Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He is the founder of special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthetics companies The Beauty Health Company and Hugel America.

References

  1. 1 2 3 "Abe Plough (1892-1984)". Tennessee Encyclopedia of History and Culture. Archived from the original on 2015-05-19.
  2. ↑ "Merck US Prescription Products". Merck.com. Archived from the original on November 4, 2010. Retrieved November 10, 2010.
  3. ↑ "Merck Consumer Products". Merck.com. Archived from the original on November 20, 2010. Retrieved November 10, 2010.
  4. ↑ "The Pharmaceutical Industry in Figures - 2008 Edition". European Federation of Pharmaceutical Industries and Associations (EFPIA). p. 49. Archived from the original on 2008-09-16. Retrieved 2008-08-25.
  5. ↑ "Trade Association Memberships". Merck.com. Archived from the original on November 19, 2010. Retrieved November 8, 2010.
  6. ↑ Federal Communications Commission (FCC) memorandum opinion and order released Tuesday, December 15, 1970 pertaining to the approval of the transfer of control of Plough Broadcasting Co., Inc. from Plough, Inc. to Schering-Plough Corp. Retrieved January 16, 2019
  7. ↑ "Schering-Plough Corp facts, information, pictures - Encyclopedia.com articles about Schering-Plough Corp". www.encyclopedia.com. Archived from the original on 16 September 2016. Retrieved 16 March 2018.
  8. ↑ "Answers - The Most Trusted Place for Answering Life's Questions". Answers.com. Archived from the original on 17 March 2018. Retrieved 16 March 2018.
  9. 1 2 "Schering-Plough Acquires Organon BioSciences". Medical Net News. 20 November 2007. Archived from the original on 20 December 2009. Retrieved 19 June 2010.
  10. ↑ Singer, Natasha (March 10, 2009). "Merck to Buy Schering-Plough for $41.1 Billion". The New York Times. Archived from the original on May 12, 2011. Retrieved 2009-11-14.
  11. ↑ "Merck and Schering-Plough to Complete Merger Today" (Press release). Merck & Co. November 3, 2009. Archived from the original on November 7, 2009. Retrieved 2009-11-13.
  12. ↑ "New Merck Begins Operations" (Press release). Merck & Co. November 4, 2009. Archived from the original on December 8, 2009. Retrieved 2009-11-13.
  13. ↑ Merck & Company, Inc. (November 12, 2009). "Notice of Reorganization Event". Posted on Thomson Reuters web site. Archived from the original (PDF) on February 1, 2016. Retrieved 2009-11-13.
  14. ↑ "About Us". Coopers Animal Health. Archived from the original on 23 March 2016. Retrieved 23 March 2016.
  15. ↑ "Intervet/Schering-Plough Animal Health". Intervet.com. Archived from the original on November 10, 2010. Retrieved November 10, 2010.
  16. ↑ "Merial, Intervet/Schering-Plough Call Off Merger". DVM Newsmagazine. 23 March 2011. Archived from the original on 18 May 2011. Retrieved 27 July 2011.
  17. ↑ "Merck Announces New Name for Its Animal Health Division". Merck Animal Health. 29 June 2011. Archived from the original on 8 August 2011. Retrieved 27 July 2011.
  18. ↑ Gupta SK, Ellinwood EH; Ellinwood (June 1988). "Liquid chromatographic assay and pharmacokinetics of quazepam and its metabolites following sublingual administration of quazepam". Pharm. Res. 5 (6): 365–8. doi:10.1023/A:1015907611170. PMID   3244647. S2CID   26259786.[ dead link ]
  19. ↑ "Zubrin". Intervet USA. Archived from the original on 18 January 2010. Retrieved 19 June 2010.
  20. ↑ "Mometamax". Intervet USA. Archived from the original on 20 June 2010. Retrieved 19 June 2010.
  21. ↑ "Feline Products". Intervet USA. Archived from the original on 20 September 2010. Retrieved 19 June 2010.
  22. ↑ "Canine Products". Intervet USA. Archived from the original on 29 May 2010. Retrieved 19 June 2010.
  23. ↑ "Optimmune". Intervet USA. Archived from the original on 6 July 2010. Retrieved 19 June 2010.
  24. ↑ "Orbax". Intervet USA. Archived from the original on 29 May 2010. Retrieved 19 June 2010.
  25. ↑ "Otomax". Intervet USA. Archived from the original on 6 August 2010. Retrieved 19 June 2010.
  26. ↑ "Bantamine Paste". Intervet USA. Archived from the original on 6 February 2010. Retrieved 19 June 2010.
  27. ↑ "Estrumate Prostaglandin". Intervet USA. Archived from the original on 14 September 2009. Retrieved 19 June 2010.
  28. ↑ "Nuflor". Intervet USA. Archived from the original on 27 August 2010. Retrieved 19 June 2010.
  29. ↑ Mattes, William B. (2008). "Public Consortium Efforts in Toxicogenomics". In Mendrick, Donna L.; Mattes, William B. (eds.). Essential Concepts in Toxicogenomics. Methods in Molecular Biology. Vol. 460. pp. 221–238. doi:10.1007/978-1-60327-048-9_11. ISBN   978-1-58829-638-2. PMID   18449490.
  30. ↑ "InnoMed PredTox Member Organizations". Archived from the original on 2008-09-26. Retrieved 2008-08-25.
  31. ↑ Gardiner Harris, "As Doctors Write Prescriptions, Drug Company Writes a Check", The New York Times (June 27, 2004) Archived September 22, 2015, at the Wayback Machine
  32. ↑ Petersen, Melody (18 May 2002). "Drug Maker to Pay $500 Million Fine For Factory Lapses". The New York Times. Archived from the original on 28 January 2018. Retrieved 16 March 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.